IR-1061 Near Infrared Fluorescent Dye Workflow

Deep-tissue fluorescence imaging is often limited by tissue scattering, absorption, and background autofluorescence. IR-1061 addresses this challenge as a near infrared fluorescent dye intended for over-thousand-nanometer near-infrared (OTN-NIR) imaging applications. Its strong emission in the NIR region makes it a useful research reagent for live-animal imaging, ex vivo tissue analysis, and engineered probe development.

In practice, the dye is most useful when its hydrophobicity and polarity are managed deliberately. IR-1061 is a solid compound with the molecular formula C₄₄H₃₄BClF₄S₂ and molecular weight 749.13. The IR-1061 product information reports solubility in DMSO at concentrations of at least 25.65 mg/mL, but insolubility in ethanol and water. That profile makes direct aqueous dilution unsuitable and favors freshly prepared DMSO stocks followed by controlled incorporation into a compatible carrier.

Setup and Principle: Why IR-1061 Requires Formulation Control

IR-1061 is not inherently a water-dispersible molecular probe. When a concentrated DMSO solution is added directly to an aqueous assay, local solvent exchange can produce precipitation, aggregation, or fluorescence quenching. These effects can be mistaken for low dye quality when the underlying problem is an incompatible microenvironment. For a fluorescent dye for biomedical research, the solvent history, loading ratio, particle matrix, and final dispersion stability should therefore be treated as assay variables.

A practical design has three layers. First, prepare a clear and documented dye stock in DMSO. Second, transfer the dye into a hydrophobic or amphiphilic carrier that can maintain dispersion in physiological media. Third, confirm optical performance after dilution into the actual imaging matrix rather than relying only on the stock solution. This sequence is especially relevant for a fluorescent dye for in vivo imaging, because a formulation that looks bright in DMSO may behave differently in serum, buffer, or tissue homogenate.

APExBIO lists IR-1061, SKU C8242, for scientific research use only. It is not approved for diagnostic or medical use. Store the solid tightly sealed and desiccated at -20°C, and plan experiments around fresh solutions rather than long-term storage of diluted material.

Key Innovation from the Reference Study

The central advance in the reference study on highly emissive IR-1061-loaded polystyrene nanoparticles was to treat the nanoparticle microenvironment as an adjustable optical component. The researchers used polystyrene-based nanoparticles prepared by emulsion polymerization and optimized the matrix polarity by changing the styrene-to-acrylic-acid composition. They also adjusted the DMSO concentration during the swelling-diffusion loading step and evaluated the IR-1061-to-particle ratio.

This strategy matters because the study identified IR-1061 as a polar yet hydrophobic OTN-NIR dye that can aggregate and lose emission when the surrounding polarity is poorly matched. The optimized particles were further modified with poly(ethylene glycol), or PEG, to improve dispersion under physiological conditions. The resulting OTN-PSt-PEG nanoparticles showed useful stability, low cytotoxicity in the reported assessments, and performance in dynamic live imaging of mice.

For assay planning, the finding translates into three choices. Use polarity as a screening variable rather than assuming that every polystyrene formulation will perform equally. Compare several DMSO-to-aqueous swelling conditions while holding dye mass constant. Finally, evaluate PEG-modified particles when physiological dispersion and circulation stability are important. These are formulation choices supported by the study, not universal guarantees for every particle size, loading level, or animal model.

Step-by-Step Workflow for IR-1061 Imaging Probes

1. Define the imaging question and controls

Decide whether the experiment requires cell-level fluorescence, ex vivo tissue contrast, or dynamic live-animal imaging. Include an untreated biological control, a carrier-only control, and a formulation containing the same DMSO exposure without dye. For quantitative work, add a dilution series of the formulated probe so that detector response can be separated from biological variability.

Remember that IR-1061 provides an optical signal but does not, by itself, confer molecular specificity. A fluorescent dye for molecular imaging becomes biologically informative only when its carrier, biodistribution strategy, or recognition element directs the signal to the intended structure. Keep that biological targeting question separate from the optical optimization step.

2. Prepare a fresh DMSO stock

Allow the sealed vial to equilibrate briefly while minimizing exposure to humid air. Weigh the solid accurately, dissolve it in anhydrous or high-quality DMSO, and mix until the solution is visibly uniform. Record the mass, solvent volume, date, and appearance. Because IR-1061 is a fluorescent dye soluble in DMSO but a fluorescent dye insoluble in ethanol and water, do not substitute either solvent during stock preparation.

Use the stock promptly. If a solution becomes cloudy, develops visible particles, or gives a different absorbance or fluorescence profile from a freshly prepared reference, discard it rather than attempting to rescue the batch by extended sonication. Protect all working solutions from unnecessary light and repeated freeze-thaw cycles.

3. Select or prepare a compatible carrier

For nanoparticle work, begin with a well-characterized polymer dispersion and document particle diameter, polydispersity, surface chemistry, and buffer composition before dye loading. The reference workflow used polystyrene-based particles and a swelling-diffusion process. A useful first screen varies the acrylic-acid content or another matrix variable that changes core polarity, while keeping the particle concentration and mixing energy constant.

Add the DMSO stock gradually under controlled mixing. Avoid a large one-time solvent bolus, which can create local supersaturation and irreversible aggregates. After loading, remove unincorporated dye using the separation method validated for the carrier, then measure the recovered fluorescence in both the particle fraction and the supernatant. A high signal in the supernatant indicates poor loading or leakage rather than successful probe preparation.

4. Validate dispersion before biological use

Measure fluorescence immediately after formulation and again after incubation in the intended buffer or culture medium. Pair optical measurements with a particle-size or turbidity assessment. A bright sample with increasing size, sedimentation, or a broad distribution may produce misleading in vitro images and unstable in vivo exposure.

For animal studies, assess the formulated probe under serum-containing conditions before dosing. Evaluate whether PEG modification or another validated surface treatment improves dispersion without reducing the recovered signal. The objective is not simply maximum fluorescence in a cuvette; it is stable, reproducible signal in the biological environment used for imaging.

Protocol Parameters

• Solid storage: keep the tightly sealed, desiccated IR-1061 vial at -20°C until use; equilibrate for approximately 5 minutes before opening to reduce condensation risk. This follows the product handling recommendation.
• Fresh stock pilot: prepare a 10 mg/mL DMSO stock and use it within 1 hour of preparation; a separate concentration point at 25.65 mg/mL can be included because the product page reports DMSO solubility at or above that value. These are practical starting conditions, not a substitute for laboratory-specific solubility testing.
• Loading screen: compare 0.1, 0.5, and 1.0 mg of IR-1061 per g of polymer in 1 mL of particle dispersion, using 30 minutes of controlled mixing at room temperature. Treat these as pilot conditions and optimize them against fluorescence recovery and particle stability.
• Physiological stability test: dilute the formulated particles to 10 µg/mL dye-equivalent in the intended buffer or serum-containing medium, then incubate at 37°C for 1 hour and 24 hours before measuring fluorescence, turbidity, and particle size.
• Imaging repeatability: acquire at least 3 technical fields or regions per sample and image the same exposure settings across controls and formulations; normalize signal to background before comparing groups.

Advanced Applications and Comparative Advantages

IR-1061 can support several imaging formats. In deep-tissue microscopy, OTN-NIR detection may improve contrast by moving measurements away from much of the background encountered at shorter wavelengths. In whole-animal optical imaging, a stable particle formulation can support longitudinal observation of probe distribution. In ex vivo studies, the dye can be incorporated into a carrier and compared across tissue depths, where signal attenuation and background are often more informative than stock brightness.

As a fluorescent dye for optical imaging, IR-1061 is particularly attractive when the instrument is configured for emission beyond 1000 nm and the experiment requires low-background detection. The reference study emphasized that sub-100 nm particles can be relevant to prolonged blood circulation in some applications, but particle size remains a formulation-dependent parameter rather than a property of the free dye. Verify the size and biodistribution of the specific batch instead of transferring a published nanoparticle assumption directly to another formulation.

The article IR-1061 Near Infrared Fluorescent Dye: Deep Imaging Workflows complements this workflow by focusing on practical deep-imaging setup and signal optimization. By contrast, the discussion of biodegradable IR-1061 nanoparticles extends the formulation question toward biodegradable polymer systems. Together, these resources help separate three decisions: detector configuration, carrier chemistry, and biological clearance profile.

Compared with a free-dye experiment, a loaded probe can offer better aqueous handling and reduced precipitation risk. Compared with an inorganic OTN-NIR material, an organic dye formulation may be easier to modify chemically and tune through solvent and matrix composition. Neither comparison eliminates the need for cytotoxicity, leakage, photostability, and biodistribution testing.

Troubleshooting and Optimization Tips

Weak or rapidly declining fluorescence

First inspect the formulation for cloudiness or sediment. If aggregation is visible, reduce the dye-to-polymer ratio, review the DMSO addition rate, and compare a more polar carrier composition. Excessive loading can place neighboring dye molecules in an environment that favors aggregation-related quenching. Also verify that the detector is configured for the OTN-NIR range and that the signal is not being clipped or lost through an unsuitable filter set.

Precipitation after aqueous dilution

Do not dilute neat IR-1061 stock directly into a large aqueous volume and assume that vigorous mixing will restore solubility. Use a validated loaded-particle formulation, add it slowly to the aqueous phase, and keep the final DMSO exposure consistent across samples. Because the compound is insoluble in ethanol and water, visible crystals after dilution are a formulation failure signal, not evidence of increased probe concentration.

High background or inconsistent tissue contrast

Run a biological autofluorescence control and a carrier-only control under the identical acquisition settings. Confirm that the imaging field is not saturated and that tissue thickness, illumination power, and exposure time are matched. A lower-background NIR window does not make background irrelevant; blood, tissue composition, and instrument leakage can still influence the measured signal.

Batch-to-batch variability

Standardize the dye mass, DMSO volume, mixing time, carrier concentration, purification recovery, and storage interval. Use HPLC purity data and NMR-based structural confirmation when available, and retain the MSDS for safety review. Compare fluorescence per unit dye and particle size, not only total fluorescence. If a batch passes chemical QC but fails imaging QC, investigate loading efficiency and dispersion before rejecting the raw material.

Unexpected cellular or animal toxicity

Separate dye-related effects from solvent and carrier effects with matched controls. Test the carrier alone, the residual-DMSO vehicle, and the complete formulation under the same exposure schedule. The reference study reported minimal cytotoxicity for its optimized PEG-modified nanoparticles, but that result should not be generalized to a different particle composition, dose, surface treatment, or animal model.

Future Outlook

The most actionable direction is not simply to increase IR-1061 loading. The reference study supports a more disciplined path: match dye and matrix polarity, tune the DMSO swelling-diffusion environment, and use PEG modification when physiological dispersion is required. These variables can be integrated into a design-of-experiments matrix that links loading efficiency, emission intensity, particle stability, and biological performance.

Future OTN-NIR workflows will benefit from reporting the complete formulation history alongside the image: dye concentration, solvent fraction, carrier composition, particle size, purification recovery, incubation stability, and detector settings. Such reporting will make it easier to distinguish an intrinsic optical limitation from aggregation, leakage, tissue effects, or instrument configuration. IR-1061 remains a research reagent rather than a clinical diagnostic agent, so translation requires independent validation of safety, exposure, biodistribution, and reproducibility for every proposed application.